Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epithelial immune regulation of inflammatory airway diseases: Chronic rhinosinusitis with nasal polyps (CRSwNP)
Ludger Klimek, Jan Hagemann, Hans‐Jürgen Welkoborsky, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 148-166
Open Access | Times Cited: 9

Showing 9 citing articles:

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Tanya M. Laidlaw, Andrew Menzies‐Gow, Scott Caveney, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 915-932
Open Access | Times Cited: 27
Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma
Sylwia Smolińska, Darío Antolín‐Amérigo, Florin‐Dan Popescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12725-12725
Open Access | Times Cited: 14
The last step to achieve barrier damage control
Ilaria Baglivo, Stefania Colantuono, Arianna Lumaca, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease
Yuga Yamashita, Kosuke Terada, Yuka Kodama, et al.
Respiratory Medicine Case Reports (2024) Vol. 50, pp. 102041-102041
Open Access | Times Cited: 4
Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
Nicola Lutzu, Agnese Favale, M. Demurtas, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
'Efficacy of biologics in NSAID-ERD: United airways from the nose to the bronchi'
Kathleen M. Buchheit, Elke Vandewalle, Hester Beatrice Emilie Elzinga, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 11, pp. 2917-2932
Closed Access | Times Cited: 2
Perspectives in Therapy of Chronic Rhinosinusitis
Jacek Brzost, Katarzyna Czerwaty, Karolina Dżaman, et al.
Diagnostics (2022) Vol. 12, Iss. 10, pp. 2301-2301
Open Access | Times Cited: 9
Subway Fine Particles (PM2.5)‐Induced Pro‐Inflammatory Response Triggers Airway Epithelial Barrier Damage Through the TLRs/NF‐κB‐Dependent Pathway In Vitro
Fanmei Zeng, Guan-hua Pang, Li‐Wen Hu, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 12, pp. 5296-5308
Open Access | Times Cited: 1
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps
Joshua Jacobs, Joseph K. Han, Jason K. Lee, et al.
Advances in Therapy (2024)
Open Access | Times Cited: 1
Page 1

Scroll to top